Decision and Details
Advance disclosure matters relating to the absorption-type merger
As this is a merger with the company's wholly owned subsidiary, it has been determined appropriate not to allot shares or provide any other consideration; it has also been determined that the assumed liabilities are expected to be performed after the merger.
Following the merger, the company's assets are expected to remain well in excess of its liabilities, and no event that would impede the performance of its obligations is currently anticipated.
| Item | Details |
|---|---|
| Matter Covered | Advance disclosure matters relating to the absorption-type merger |
| Decision Date | 1 July 2026 (date of execution of the absorption-type merger agreement) |
| Implementation Date | 1 October 2026 (scheduled; effective date) |
| Amount | 68th Series Unsecured Corporate Bonds: total issue amount ¥20,000 million; 69th Series Unsecured Corporate Bonds: total issue amount ¥30,000 million |
| Impact on Business Performance | Following the merger, the company's assets are expected to remain well in excess of its liabilities, and no event that would impede the performance of its obligations is currently anticipated. |
| Reason | As this is a merger with the company's wholly owned subsidiary, it has been determined appropriate not to allot shares or provide any other consideration; it has also been determined that the assumed liabilities are expected to be performed after the merger. |
| Governing Rule | Article 794, Paragraph 1 of the Companies Act and Article 191 of the Ordinance for Enforcement of the Companies Act |
| Future plans | The absorption-type merger is scheduled to take effect on 1 October 2026. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As this is a merger with a wholly owned subsidiary, it has been determined appropriate not to allot shares or provide any other consideration. The company expects no impediment to the performance of the liabilities assumed after the merger.